MetaCap

Pharvaris N.V. Company Profile

NASDAQ: PHVSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

31.28-0.38 (-1.20%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Pharvaris N.V. at a glance

Pharvaris N.V. (NASDAQ: PHVS) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Zug, Netherlands. Pharvaris N.V. is led by Mr. Berndt Axel Edvard Modig CPA, M.B.A. and employs about 168 people. The company's shares have traded publicly since 2021.

At a market capitalization of $2.21 billion, it is considered a mid-cap company. Its SEC Central Index Key (CIK) is 0001830487, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Pharvaris N.V. do?

Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist to treat attacks due to bradykinin-mediated angioedema, including hereditary angioedema (HAE) and acquired angioedema due to C1-inhibitor deficiency (AAE-C1INH), which is in phase 3, as well as in phase 3 trials for treatment and prophylaxis of HAE attacks; and extended-release tablet and immediate-release capsule formulation of deucrictibant. Pharvaris N.V. was incorporated in 2015 and is headquartered in Zug, Switzerland.

Business description based on the company's public filings.

Company information

Legal name
Pharvaris N.V.
Ticker
NASDAQ: PHVS
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Berndt Axel Edvard Modig CPA, M.B.A.
Employees
168
Headquarters
Grafenauweg 8, Zug, Netherlands
Phone
31 712036410
IPO year
2021
SEC CIK
0001830487

Companies similar to Pharvaris N.V.

PHVS peer companies
CompanyPrice% ChgMarket capCompare
NAMSNewAmsterdam Pharma Company N.V.18.41-5.64%$2.21Bvs PHVS
PRGOPerrigo Company plc15.94-0.62%$2.21Bvs PHVS
LKFTLakefront Biotherapeutics ADR33.31-0.24%$2.18Bvs PHVS
RCUSArcus Biosciences Inc.15.62-1.01%$2.25Bvs PHVS
HCMHUTCHMED (China) Limited ADR13.22-1.71%$2.30Bvs PHVS
PVLAPalvella Therapeutics Inc.142.85-2.00%$2.09Bvs PHVS
PBHPrestige Consumer Healthcare Inc.49.63+0.06%$2.35Bvs PHVS
AUPHAurinia Pharmaceuticals Inc14.70-1.28%$1.97Bvs PHVS

Related